BIOTRONIK has just an**unced that its Closed Loop Stimulation (CLS) physiologic sensor is **w Available on the Itrevia cardiac resynchronization therapy defibrillator (CRT-D) in the United States. The CLS sensor adjusts the patient Heart rate in response to physical activity, even when there’s ** change in the respiratory rate or body movement.
Typically, CRT-Ds monitor patient movements using a built-in accelerometer, but that can be deceptive depending on the physical activity. The CLS tech**logy uses impedance sensing to compensate for changing mental stress, similar to how the body’s own healthy nervous system works coordinates with the heart.
From the an**uncement:
The latest BIOTRONIK Itrevia ICD and CRT-D ******* includes other advanced atrial therapies: morphology discrimination, Vp Suppression®, atrial capture control, improved ATP optimization and LV Pacing vectors. Combined, they create more therapeutic options to deliver effective therapy while reducing painful shocks. All devices include BIOTRONIK Home Monitoring®, the first remote monitoring system and the only system with automatic daily transmission, which has been shown to reduce all-cause mortality by over 50 percent3.
“CLS is the only FDA-approved sensor to respond to acute mental stress on a beat-to-beat basis,” said Marlou Janssen, President, BIOTRONIK, Inc. “We are very pleased to make this unique tech**logy Available for Heart failure patients. CLS is a**ther BIOTRONIK core tech**logy that works to improve the quality of patients’ lives, allowing them to experience a wider range of physiologic responses than with other CRM devices.”